PreludeDx and Quanterix announce breast cancer test validation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to PreludeDx and Quanterix announce breast cancer test validation
(NASDAQ: QTRX) Delayed: 3.10 +0.07 (2.31%)
Previous Close $3.03    52 Week High $ 
Open $3.03    52 Week Low $ 
Day High $3.17    P/E N/A 
Day Low $2.98    EPS $ 
Volume 706,324